AzTrials
AzTrials

Morbidity;InfantNCT06444958

Morbidity and Mortality Rates Among Children Aged 0-59 Months

An observational study of Morbidity;Infant, run by Kalkaal Hospital at 1 site in Somalia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This retrospective observational study aimed to investigate the patterns of morbidity and mortality among children under 5 years of age in the population served by Kalkaal Hospital. Read more about this study

Who is it for?
Ages 0 to 59 months
Conditions the study is for
Morbidity;Infant
What is being tested?
observational study without any intervention component.
How many people
1,675 participants
Where
1 siteSomalia
Study dates
1 Jan 2023to 15 Dec 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 0 to 59 months
  • All sexes
  • Child

Study population: Children under 5 years of age in the population served by Kalkaal Hospital The target population was the pediatric patients under the age of 5 who accessed healthcare services at Kalkaal Hospital. The researchers extracted data from the hospital's records on all children under 5 who presented as outpatients, were admitted as inpatients, or were recorded in the mortality database.

Who may be able to join

  • Children aged 0-59 months who were admitted to Kalkaal Hospital during the specified study period.
  • Medical records with complete and adequate information regarding age, gender, presenting symptoms, and diagnoses.
  • -

Who cannot join

  • Children outside the age range of 0-59 months.
  • Medical records with missing or incomplete information necessary for the analysis.
  • Children admitted to Kalkaal Hospital for reasons unrelated to the study objectives (adult patients, non-pediatric cases).

Trial locations and contacts

1 site in 1 country.

Somalia1 site
  • Kalkaal Hospital

    Mogadishu, Banadir, +252

About this study

Official title: Morbidity and Mortality Rates Among Children Aged 0-59 Months: A Cross-sectional Study From Mogadishu, Somalia

This retrospective observational study aimed to investigate the patterns of morbidity and mortality among children under 5 years of age in the population served by Kalkaal Hospital. Researchers analyzed 2023 data from the hospital's electronic medical records and administrative databases to identify the most common pediatric diagnoses and causes of illness and death in this community.

Read the detailed description

This study investigated the patterns of morbidity and mortality among children under 5 years of age in the population served by Kalkaal Hospital. The specific objectives were to:

Identify the most common diagnoses and causes of illness and death in the under-5 population presenting to Kalkaal Hospital.

Analyze demographic factors (e.g. age, sex) associated with certain disease profiles and health outcomes.

Evaluate treatment practices, health service utilization, and mortality rates for the key pediatric health issues identified.

Provide a comprehensive epidemiological assessment of the burden of childhood illness and mortality in this local community.

Methods:

This was a retrospective, observational study that analyzed 2023 data from the electronic medical records and administrative databases of Kalkaal Hospital. The researchers extracted and analyzed the following data:

Outpatient department records: Diagnoses, treatments, patient demographics Inpatient admission records: Admission diagnoses, treatments, patient outcomes (discharged, transferred, died) Mortality records: Causes of death for pediatric patients The data was cleaned, coded, and analyzed using statistical software. Descriptive statistics were calculated to characterize the morbidity and mortality patterns. Regression analyses were conducted to identify demographic and clinical factors associated with key health outcomes.

Being tested
observational study without any intervention component.

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • observational study without any intervention component.Diagnostic test

    extracting and analyzing the following data:

    Outpatient department records: Diagnoses, treatments, patient demographics Inpatient admission records: Admission diagnoses, treatments, patient outcomes (discharged, transferred, died) Mortality records: Causes of death for pediatric patients

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Incidence Rate of Morbidities: Incidence rates of various morbidities among children presenting to the outpatient department and inpatient wards.

    This outcome measure will calculate the incidence rates of various morbidities among children under 18 years of age who presented to the Kalkaal Hospital outpatient department or were admitted to the inpatient wards during the 5-year study period (2018-2022). The incidence rates will be reported for the top 10 most common morbidities observed in the study population.

    Measured: JANUARY-DECEMBER 2023

  2. Mortality Rate by Age Group: Mortality rates and associated risk factors across different age groups of children under 18 (under 28 days, 29-365 days, 1-5 years).

    This outcome measure will determine the mortality rates among children under 18 years of age treated at Kalkaal Hospital, stratified by the following age groups: under 28 days, 29-365 days, and 1-5 years. The analysis will also identify risk factors associated with mortality in each age group.

    Measured: JANUARY-DECEMBER 2023

  3. Average Length of Hospital Stay: Median hospital stay duration for children under 18 years old.

    This outcome measure will calculate the median length of hospital stay for children under 18 years old who were admitted to the Kalkaal Hospital inpatient wards during the study period. The average length of stay will be reported overall, as well as by primary diagnosis categories.

    Measured: JANUARY-DECEMBER 2023

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Jun 2024
  2. Study start1 Jan 2023
  3. Primary completion15 Dec 2023
  4. Study completion15 Dec 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Retrospective
Enrolment
1,675 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06444958
Sponsor's protocol ID
KHRC2024/050
Status last verified
May 2024
First submitted
30 May 2024
Last updated
6 Jun 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: Data Sharing Plan: The de-identified individual patient data (IPD) collected and analyzed for this retrospective observational study on pediatric morbidity and mortality at Kalkaal Hospital will be made available to other researchers upon reasonable request.

Questions about this trial

What is this clinical trial studying?

An observational study of Morbidity;Infant, run by Kalkaal Hospital at 1 site in Somalia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Jun 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Somalia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Incidence Rate of Morbidities: Incidence rates of various morbidities among children presenting to the outpatient department and inpatient wards. (time frame: JANUARY-DECEMBER 2023). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jun 2024; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in